Stand Up To Cancer and SandboxAQ Launch Collaboration to Advance Treatment Innovation

6.5.2025
A laboratory monitor displaying diagnostic data from SandboxAQ's medical AI work

Stand Up To Cancer (SU2C), a nonprofit that funds cancer research, and SandboxAQ announced a collaboration applying SandboxAQ's Large Quantitative Models (LQMs), AI systems built on physics and chemistry equations rather than statistical text prediction, to SU2C-funded research projects aimed at accelerating development of new cancer treatments. The partnership pairs SandboxAQ's physics-based modeling approach, already used elsewhere in drug discovery, with SU2C's network of funded research teams working on treatment development. SandboxAQ is a Parkway Venture Capital portfolio company.

Read the full article: Stand Up To Cancer's announcement

Share
Greatness lies ahead
Sign up for updates from the cutting edge of deep tech venture capital.